Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
Index- P/E233.03 EPS (ttm)0.02 Insider Own87.20% Shs Outstand13.98M Perf Week-6.53%
Market Cap15.14M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.38M Perf Month273.19%
Income0.55M PEG- EPS next Q- Inst Own21.31% Short Float / Ratio12.80% / 0.10 Perf Quarter-52.23%
Sales0.00M P/S- EPS this Y- Inst Trans2.63% Short Interest0.05M Perf Half Y-50.34%
Book/sh2.73 P/B1.89 EPS next Y- ROA0.68% Target Price- Perf Year-48.24%
Cash/sh0.10 P/C54.08 EPS next 5Y- ROE0.73% 52W Range0.95 - 25.00 Perf YTD-49.76%
Dividend- P/FCF- EPS past 5Y- ROI3.21% 52W High-79.40% Beta2.58
Dividend %- Quick Ratio0.17 Sales past 5Y0.00% Gross Margin- 52W Low442.11% ATR1.00
Employees3 Current Ratio0.17 Sales Q/Q- Oper. Margin0.00% RSI (14)63.56 Volatility46.56% 31.51%
OptionableNo Debt/Eq0.04 EPS Q/Q-708.82% Profit Margin- Rel Volume3.29 Prev Close3.54
ShortableYes LT Debt/Eq0.00 Earnings- Payout0.00% Avg Volume472.03K Price5.15
Recom- SMA20115.05% SMA50118.20% SMA200-39.14% Volume1,552,738 Change45.48%
Nov-02-23 08:30AM
Oct-30-23 08:39AM
Oct-11-23 08:30AM
Oct-06-23 09:29AM
09:01AM Loading…
Sep-22-23 09:01AM
Sep-20-23 05:40PM
Sep-13-23 08:30AM
Sep-07-23 04:30PM
Aug-31-23 04:05PM
Aug-16-23 08:30AM
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships. Its medical needs in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heilbron Jack KendrickFormer CEO,director&10% ownerSep 22Option Exercise0.004,060,25004,060,250Sep 26 05:30 PM